<DOC>
	<DOCNO>NCT01844726</DOCNO>
	<brief_summary>The present study propose evaluate potential cognitive enhance effect GLYX-13 , NMDAR partial agonist , among group healthy adult psychiatric illness series functional magnetic resonance imaging ( fMRI ) learn memory task .</brief_summary>
	<brief_title>Effects GLYX-13 Learning Memory Healthy Individuals Those With Psychiatric Illness</brief_title>
	<detailed_description>In single blind randomize parallel group design , evaluate whether single dose GLYX-13 vs. placebo increase cognitive performance task learn , declarative memory , work memory , associate task-related increase BOLD activation hippocampus dorsolateral prefrontal cortex , respectively . Positive finding provide biomarker evidence GLYX-13 effect neural system underlie cognitive process .</detailed_description>
	<mesh_term>Mental Disorders</mesh_term>
	<criteria>For Individuals Male female subject Ages 18 40 year General intellectual ability fall broadly within average range ( estimate IQ 80 119 ) Sufficient ability understand study requirement provide write informed consent For Patients Diagnosis Schizophrenia Schizoaffective Disorder For individual : History neurologic disorder systemic medical condition may interfere central nervous system function History seizures History heard injury loss consciousness concussion Positive screen drug abuse : cocaine , marijuana , PCP , ketamine , opioid , agent abused opinion investigator Females currently pregnant plan become pregnant study period History allergy , sensitivity , intolerance NmethylDAspartate receptor ( NMDAR ) ligands include ketamine , dextromethorphan , memantine , methadone , dextropropoxyphene , ketobemidone History ferromagnetic object body Presence medical device implant MRI contraindicate include cardiac pacemaker , aneurysm clip , cochlear implant , copper intrauterine device ( IUD ) , neurostimulator , device deem unsafe Bullet shrapnel body Metallic brace permanent retainer Significant claustrophobia For Healthy Individuals Personal history Axis I disorder accord SCID criterion History treatment antidepressant , antipsychotic , stimulant , sedative/ hypnotic , mood stabilizing , anticholinergic medication lithium History among firstdegree family member psychotic illness major mood disorder ( e.g. , major depressive disorder , recurrent ; bipolar I II disorder ) For Patients Treatment Clozaril Change medication within 1 month Hospitalization within 1 month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>40 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>healthy individual</keyword>
	<keyword>schizophrenia</keyword>
	<keyword>schizoaffective disorder</keyword>
	<keyword>learn</keyword>
	<keyword>memory</keyword>
	<keyword>cognitive enhancement</keyword>
	<keyword>fMRI</keyword>
</DOC>